FDA
approval
· 2023-03-02
FDA Approved: VIGABATRIN — Original Application (Zydus Lifesciences Limited)
Summary
FDA approves Zydus Lifesciences Limited's original ANDA for Vigabatrin, allowing a generic version of the anti-epileptic drug. The approval covers the same indi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for VIGABATRIN (VIGABATRIN)